Proposed FDA Rule Preempts State Product Liability Laws
The National Conference of State Legislatures (NCSL) is charging the FDA with pre-empting states’ rights to prosecute drug product liability laws by proposing a drug-labeling policy change. The NCSL says that FDA refused to provide the exact language of the proposed rule but said the rule would impact several cases already under way. I’ll keep an eye on this evolving story.
